SCHEMBL7709161

SCHEMBL7709161

COc1ccc(-c2cc(N)n3nc(-c4ccc(C)o4)nc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 12/20 0.53
KDM4E B2RXH2 3/20 0.52
NPC1 O15118 3/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
PKM P14618 1/20 0.52
CDK5 Q00535 1/20 0.52
CDK5R1 Q15078 1/20 0.52
ADORA3 P0DMS8 2/20 0.40
ADORA1 P30542 2/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711750 0.88 ADORA2A (0.57) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7487041 0.88 ADORA2A (0.51) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7492811 0.87 ADORA2A (0.52) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7708869 0.86 ADORA2A (0.49) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7491175 0.86 ADORA2A (0.55) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7711685 0.86 ADORA2A (0.57) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7705907 0.85 ADORA2A (0.56) ADORA2AKDM4EALDH1A1ADORA3ADORA1
SCHEMBL7709141 0.84 ADORA2A (0.53) ADORA2AKDM4EALDH1A1ADORA3ADORA1
SCHEMBL7708958 0.83 ADORA2A (0.53) ADORA2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL7708891 0.82 KDM4E (0.49) ADORA2AKDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed